North America Poultry Vaccines Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Broiler, Layer, and Breeder), Technology (Live Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines, and Others), Dosage Form (Liquid vaccines, Freeze-Dried Vaccines, and Dust/Powdered Vaccines), Disease [Newcastle Disease, Avian Influenza, Marek's Disease, Infectious Bronchitis (IB), Infectious Bursal Disease (IBD), Salmonellosis, and Others], Route of Administration [Drinking Water (D/W) and Spray, Intramuscular (I/M), Subcutaneous (S/C), and Others], and End User (Poultry Farms and Hatcheries, Veterinary Hospitals, and Poultry Vaccination Centers and Clinics)
The North America poultry vaccines market is expected to reach US$ 1,256.14 million by 2028 from US$ 808.91 million in 2021. The market is estimated to grow at a CAGR of 6.5% from 2021 to 2028.
Poultry vaccine assists in averting a specific disease by accelerating the bird's immune system to generate antibodies to battle against the invading organisms. Poultry vaccines are essential for poultry disease control and the prevention of viral diseases. Vaccination helps prevent or reduce the adverse effects of specific conditions that can cause problems, such as infections in a poultry flock. Poultry vaccines are widely applied to avoid contagious poultry diseases and minimize the emergence of clinical disease at the farm level, thus, increasing production. Zoonotic diseases, avian influenza viruses, and bird flu are the major poultry diseases.The North America poultry vaccines market is expected to grow at a good CAGR during the forecast period.
North America Poultry Vaccines Revenue and Forecast to 2028 (US$ million)
North America Poultry Vaccines Market Segmentation
The North America poultry vaccines market is segmented based on type, technology, dosage form, disease, route of administration, end user, and country. Based on type, the market is segmented into broiler, layer, and breeder. The breeder segment dominated the North America poultry vaccines market in 2020. In terms of technology, the market is segmented into live attenuated vaccines, inactivated vaccines, recombinant vaccines, and others. The live attenuated vaccines segment dominated the North America poultry vaccines market in 2020. Based on dosage form, the market is segmented into liquid vaccines, freeze-dried vaccines, and dust/powdered vaccines. The liquid vaccines segment dominated the North America poultry vaccines market in 2020. Based on disease, the market is segmented into Newcastle disease, avian influenza, Marek's disease, infectious bronchitis (IB), infectious bursal disease (IBD), salmonellosis, and others. The Newcastle disease dominated the North America poultry vaccines market in 2020. Based on route of administration, the market is segmented into drinking water (d/w) and spray, intramuscular (i/m), subcutaneous (s/c), and others. The drinking water (d/w) and spray segment dominated the North America poultry vaccines market in 2020. Based on end user, the market is segmented into poultry farms & hatchery, veterinary hospitals, and poultry vaccination centers & clinics. The poultry farms & hatchery segment dominated the North America poultry vaccines market in 2020. Based on country, the North America poultry vaccines market is segmented into the US, Mexico, and Canada. The US dominated the North America poultry vaccines market in 2020.
Boehringer Ingelheim International GmbH, Zoitis Inc., Ceya Santae Animale, BIOVAC, PHIBRO ANIMAL HEALTH CORPORATION, Hester Biosciences Limited, Dechra Pharmaceutical Plc, Elanco, and Merck Animal Health are among the leading companies in North America poultry vaccines market.
1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Poultry Vaccines Market – By Type
1.3.2 North America Poultry Vaccines Market – By Technology
1.3.3 North America Poultry Vaccines Market – By Dosage Form
1.3.4 North America Poultry Vaccines Market – By Disease
1.3.5 North America Poultry Vaccines Market – By Route of Administration
1.3.6 North America Poultry Vaccines Market – By End User
1.3.7 North America Poultry Vaccines Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Poultry Vaccines Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.3 Experts Opinion
5. North America Poultry Vaccines Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Diseases in Poultry
5.1.2 Increasing Demand for Healthy Poultry Food
5.2 Market Restraints
5.2.1 Failure of Vaccines in Poultry Production
5.3 Market Opportunities
5.3.1 Rising Growth of Market in Untapped Economies
5.4 Future Trends
5.4.1 Key Business Strategies to Enhance Market Growth in Future
5.5 Impact Analysis
6. Poultry Vaccines Market– North America Analysis
6.1 North America Poultry Vaccines Market Revenue Forecast and Analysis
6.1.1 Poultry Vaccines Market Revenue Forecast and Analysis
7. North America Poultry Vaccines Market Analysis – By Type
7.1 Overview
7.2 Poultry Vaccines Market Revenue Share, by Type (2021 and 2028)
7.3 Broiler
7.3.1 Overview
7.3.2 Broiler: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Layer
7.4.1 Overview
7.4.2 Layer: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Breeder
7.5.1 Overview
7.5.2 Breeder: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
8. North America Poultry Vaccines Market Analysis – By Technology
8.1 Overview
8.2 Poultry Vaccines Market Revenue Share, by Technology (2021 and 2028)
8.3 Live Attenuated Vaccines
8.3.1 Overview
8.3.2 Live attenuated vaccines: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Inactivated Vaccines
8.4.1 Overview
8.4.2 Inactivated Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Recombinant Vaccines
8.5.1 Overview
8.5.2 Recombinant Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
9. North America Poultry Vaccines Market Analysis – By Dosage Form
9.1 Overview
9.2 Poultry Vaccines Market Revenue Share, by Dosage Form (2021 and 2028)
9.3 Liquid Vaccines
9.3.1 Overview
9.3.2 Liquid Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Freeze-Dried Vaccines
9.4.1 Overview
9.4.2 Freeze-Dried Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Dust/Powdered Vaccines
9.5.1 Overview
9.5.2 Dust/Powdered Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
10. Poultry Vaccines Market Analysis – By Disease
10.1 Overview
10.2 Poultry Vaccines Market Revenue Share, by Disease (2021 and 2028)
10.3 Infectious Bronchitis
10.3.1 Overview
10.3.2 Infectious Bronchitis: Poultry vaccines Market – Revenue and Forecast to 2028 (US$ Million)
10.4 Avian Influenza
10.4.1 Overview
10.4.2 Avian Influenza: Poultry vaccines Market – Revenue and Forecast to 2028 (US$ Million)
10.5 Marek's Disease
10.5.1 Overview
10.5.2 Marek’s Disease: Poultry vaccines Market – Revenue and Forecast to 2028 (US$ Million)
10.6 Infectious Bursal Disease
10.6.1 Overview
10.6.2 Infectious Bursal Disease: Poultry vaccines Market – Revenue and Forecast to 2028 (US$ Million)
10.7 Salmonellosis
10.7.1 Overview
10.7.2 Salmonellosis: Poultry vaccines Market – Revenue and Forecast to 2028 (US$ Million)
10.8 Newcastle Disease
10.8.1 Overview
10.8.2 Newcastle Disease: Poultry vaccines Market – Revenue and Forecast to 2028 (US$ Million)
10.9 Others
10.9.1 Overview
10.9.2 Others: Poultry vaccines Market – Revenue and Forecast to 2028 (US$ Million)
11. North America Poultry vaccines Market Analysis – By Route of Administration
11.1 Overview
11.2 Poultry vaccines Market Revenue Share, by Route of Administration (2021 and 2028)
11.3 Drinking water (D/W) & Spray
11.3.1 Overview
11.3.2 Drinking water (D/W) & Spray: Poultry vaccines Market – Revenue and Forecast to 2028 (US$ Million)
11.4 Intramuscular (I/M)
11.4.1 Overview
11.4.2 Intramuscular (I/M): Poultry vaccines Market – Revenue and Forecast to 2028 (US$ Million)
11.5 Subcutaneous (S/C)
11.5.1 Overview
11.5.2 Subcutaneous (S/C): Poultry vaccines Market – Revenue and Forecast to 2028 (US$ Million)
11.6 Others
11.6.1 Overview
11.6.2 Others: Poultry vaccines Market – Revenue and Forecast to 2028 (US$ Million)
12. North America Poultry vaccines Market Analysis – By End User
12.1 Overview
12.2 Poultry vaccines Market Share, by End User, 2021 and 2028, (%)
12.3 Veterinary Hospitals
12.3.1 Overview
12.3.2 Veterinary Hospitals: Poultry vaccines Market – Revenue and Forecast to 2028 (US$ Million)
12.4 Poultry Vaccination Centers & Clinics
12.4.1 Overview
12.4.2 Poultry Vaccination Centre: Poultry vaccines Market – Revenue and Forecast to 2028 (US$ Million)
12.5 Poultry Farms and Hatchery
12.5.1 Overview
12.5.2 Poultry Farms and Hatchery: Poultry vaccines Market – Revenue and Forecast to 2028 (US$ Million)
13. North America Poultry vaccines Market – Country Analysis
13.1 North America: Poultry vaccines Market
13.1.1 Overview
13.1.2 North America: Poultry vaccines Market, by Country, 2021 & 2028 (%)
13.1.2.1 US: Poultry vaccines Market – Revenue and Forecast to 2028 (US$ Million)
13.1.2.1.1 US: Poultry vaccines Market – Revenue and Forecast to 2028 (US$ Million)
13.1.2.1.2 U.S. Poultry vaccines Market, by Type – Revenue and Forecast to 2028 (US$ Million)
13.1.2.1.3 U.S. Poultry vaccines Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
13.1.2.1.4 U.S. Poultry vaccines Market, by Dosage Form – Revenue and Forecast to 2028 (US$ Million)
13.1.2.1.5 U.S. Poultry vaccines Market, by Disease – Revenue and Forecast to 2028 (US$ Million)
13.1.2.1.6 U.S. Poultry vaccines Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
13.1.2.1.7 U.S. Poultry vaccines Market, by End User – Revenue and Forecast to 2028 (US$ Million)
13.1.2.2 Canada: Poultry vaccines Market – Revenue and Forecast to 2028 (US$ Million)
13.1.2.2.1 Canada: Poultry vaccines Market – Revenue and Forecast to 2028 (US$ Million)
13.1.2.2.2 Canada Poultry vaccines Market, by Type – Revenue and Forecast to 2028 (US$ Million)
13.1.2.2.3 Canada Poultry vaccines Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
13.1.2.2.4 Canada Poultry vaccines Market, by Dosage Form – Revenue and Forecast to 2028 (US$ Million)
13.1.2.2.5 Canada Poultry vaccines Market, by Disease – Revenue and Forecast to 2028 (US$ Million)
13.1.2.2.6 Canada Poultry vaccines Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
13.1.2.2.7 Canada Poultry vaccines Market, by End User – Revenue and Forecast to 2028 (US$ Million)
13.1.2.3 Mexico: Poultry vaccines Market – Revenue and Forecast to 2028 (US$ Million)
13.1.2.3.1 Mexico: Poultry vaccines Market – Revenue and Forecast to 2028 (US$ Million)
13.1.2.3.2 Mexico Poultry vaccines Market, by Type – Revenue and Forecast to 2028 (US$ Million)
13.1.2.3.3 Mexico Poultry vaccines Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
13.1.2.3.4 Mexico Poultry vaccines Market, by Dosage Form– Revenue and Forecast to 2028 (US$ Million)
13.1.2.3.5 Mexico Poultry vaccines Market, by Disease – Revenue and Forecast to 2028 (US$ Million)
13.1.2.3.6 Mexico Poultry vaccines Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
13.1.2.3.7 Mexico Poultry vaccines Market, by End User – Revenue and Forecast to 2028 (US$ Million)
14. Industry Landscape
14.1 Overview
14.2 Organic Developments
14.2.1 Overview
14.3 Inorganic Developments
14.3.1 Overview
15. Company Profiles
15.1 Boehringer Ingelheim International GmbH
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Products and Services
15.1.4 Financial Overview
15.1.5 SWOT Analysis
15.1.6 Key Developments
15.2 Zoetis Inc.
15.2.1 Key Facts
15.2.2 Business Description
15.2.3 Products and Services
15.2.4 Financial Overview
15.2.5 SWOT Analysis
15.2.6 Key Developments
15.3 Ceva Santé Animale
15.3.1 Key Facts
15.3.2 Business Description
15.3.3 Products and Services
15.3.4 Financial Overview
15.3.5 SWOT Analysis
15.3.6 Key Developments
15.4 BIOVAC
15.4.1 Key Facts
15.4.2 Business Description
15.4.3 Products and Services
15.4.4 Financial Overview
15.4.5 SWOT Analysis
15.4.6 Key Developments
15.5 PHIBRO ANIMAL HEALTH CORPORATION
15.5.1 Key Facts
15.5.2 Business Description
15.5.3 Products and Services
15.5.4 Financial Overview
15.5.5 SWOT Analysis
15.5.6 Key Developments
15.6 Hester Biosciences Limited
15.6.1 Key Facts
15.6.2 Business Description
15.6.3 Products and Services
15.6.4 Financial Overview
15.6.5 SWOT Analysis
15.6.6 Key Developments
15.7 Dechra Pharmaceuticals PLC
15.7.1 Key Facts
15.7.2 Business Description
15.7.3 Products and Services
15.7.4 Financial Overview
15.7.5 SWOT Analysis
15.7.6 Key Developments
15.8 Elanco
15.8.1 Key Facts
15.8.2 Business Description
15.8.3 Products and Services
15.8.4 Financial Overview
15.8.5 SWOT Analysis
15.8.6 Key Developments
15.9 Merck Animal Health
15.9.1 Key Facts
15.9.2 Business Description
15.9.3 Products and Services
15.9.4 Financial Overview
15.9.5 SWOT Analysis
15.9.6 Key Developments
16. Appendix
16.1 About the Insight Partners
16.2 Glossary of Terms
LIST OF TABLES
Table 1. U.S. Poultry vaccines Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 2. U.S. Poultry vaccines Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 3. U.S. Poultry vaccines Market, by Dosage Form – Revenue and Forecast to 2028 (US$ Million)
Table 4. U.S. Poultry vaccines Market, by Disease – Revenue and Forecast to 2028 (US$ Million)
Table 5. U.S. Poultry vaccines Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)
Table 6. U.S. Poultry vaccines Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 7. Canada Poultry vaccines Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 8. Canada Poultry vaccines Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 9. Canada Poultry vaccines Market, by Dosage Form– Revenue and Forecast to 2028 (US$ Million)
Table 10. Canada Poultry vaccines Market, by Disease– Revenue and Forecast to 2028 (US$ Million)
Table 11. Canada Poultry vaccines Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)
Table 12. Canada Poultry vaccines Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 13. Mexico Poultry vaccines Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 14. Mexico Poultry vaccines Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 15. Mexico Poultry vaccines Market, by Dosage Form – Revenue and Forecast to 2028 (US$ Million)
Table 16. Mexico Poultry vaccines Market, by Disease– Revenue and Forecast to 2028 (US$ Million)
Table 17. Mexico Poultry vaccines Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 18. Mexico Poultry vaccines Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 19. Organic Developments in the Poultry Vaccine Market
Table 20. Inorganic Developments in the Poultry Vaccine Market
Table 21. Glossary of Terms
LIST OF FIGURES
Figure 1. North America Poultry Vaccines Market Segmentation
Figure 2. North America Poultry Vaccines Market, By Country
Figure 3. North America Poultry Vaccines Market Overview
Figure 4. Breeder Segment Held Largest Share of Type Segment in North America Poultry Vaccines Market
Figure 5. North America Poultry Vaccine Market, By Country
Figure 6. North America: PEST Analysis
Figure 7. North America Experts Opinion
Figure 8. North America Poultry Vaccines Market: Impact Analysis of Drivers and Restraints
Figure 9. North America Poultry Vaccines Market– Revenue Forecast and Analysis – 2020- 2028
Figure 10. North America Poultry Vaccines Market Revenue Share, by Type (2021 and 2028)
Figure 11. North America Broiler: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. North America Layer: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. North America Breeder: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. North America Poultry Vaccines Market Revenue Share, by Technology (2021 and 2028)
Figure 15. North America Live attenuated vaccines: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. North America Inactivated Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. North America Recombinant Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. North America Others: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. North America Poultry Vaccines Market Revenue Share, by Dosage Form (2021 and 2028)
Figure 20. North America Liquid Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. North America Freeze-Dried Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. North America Dust/Powdered Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. North America Poultry Vaccines Market Revenue Share, by Disease (2021 and 2028)
Figure 24. North America Infectious Bronchitis: Poultry vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. North America Avian Influenza: Poultry vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. North America Marek’s Disease: Poultry vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. North America Infectious Bursal Disease: Poultry vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. North America Salmonellosis: Poultry vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. North America Newcastle Disease: Poultry vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. North America Others: Poultry vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. North America Poultry vaccines Market Revenue Share, by Route of Administration (2021 and 2028)
Figure 32. North America Drinking water (D/W) & spray: Poultry vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. North America Intramuscular (I/M): Poultry vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34. North America Subcutaneous (S/C): Poultry vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. North America Others: Poultry vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 36. North America Poultry vaccines Market Share, by End User, 2021 and 2028 (%)
Figure 37. North America Veterinary Hospitals: Poultry vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 38. North America Poultry Vaccination Centre: Poultry vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 39. North America Poultry Farms and Hatchery: Poultry vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 40. North America: Poultry vaccines Market, by Key Country – Revenue (2021) (US$ Million)
Figure 41. North America: Poultry vaccines Market, by Country, 2021 & 2028 (%)
Figure 42. US: Poultry vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 43. Canada: Poultry vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 44. Mexico: Poultry vaccines Market – Revenue and Forecast to 2028 (US$ Million)
1.Boehringer Ingelheim Intrnational GmbH.
2.Zoitis Inc.
3.Ceya Santae Animale.
4.BIOVAC.
5.PHIBRO ANIMAL HEALTH CORPORATION.
6.Hester Biosciences Limited.
7.Dechra Pharmaceutical Plc.
8. Elanco.
9.Merck Animal Health.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America Poultry Vaccines market forecast.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in North America Poultry Vaccines market forecast, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the poultry vaccines market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.